Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

alvaro gonzalez cantero headshot

Álvaro

González-Cantero

,

MD, PhD

Consultant Dermatologist, Associate Professor
Hospital Ramón y Cajal University Hospital
Madrid
,
Spain
2021 Fellow
Councilor Since: January 1, 2023
IPC Councilor
Dr. Alvaro González-Cantero, MD, PhD, works as a dermatologist at the Department of Dermatology of the Ramón y Cajal University Hospital in Madrid, Spain, where he combines patient care with research. He received his PhD in psoriasis and comorbidities in 2019. He is the principal investigator for a cohort study investigating the pathophysiological mechanisms underlying cardiovascular comorbidity in psoriasis. Dr. González-Cantero has received independent and competitive research funding as principal investigator from the National Psoriasis Foundation (NPF) and the Spanish government. He has published extensively on the link between inflammation, atherosclerosis, and metabolic diseases in prestigious journals such as the Journal of Investigative Dermatology, Lancet, and the European Journal of Preventive Cardiology, among others. He has lectured on psoriasis at international meetings (AAD, EADV, SID). Dr. Gonzalez-Cantero has received numerous local and national awards and honors, including being named the best specialist in Spain. He is actively involved in several foundations and organizations in membership and leadership capacities, including the International Psoriasis Council (IPC), the Psoriasis Task Force of the EADV, and the National Psoriasis Foundation. He also serves as a reviewer for several international grant organizations and biomedical journals.
Last Updated:
11/04/2022

Areas of Interest

Psoriasis and comorbidities; the impact of psoriasis treatments on comorbidities; early intervention in psoriasis; psoriasis and lifestyle; mechanistic studies in psoriasis.

IPC Committees / Groups

Disease Severity Working Group

Languages Spoken

English, Spanish

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026